Market Overview:
The global osteoarthritis medications market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of osteoarthritis, rising geriatric population, and technological advancements in the field of osteoarthritis medications. The global osteoarthritis medications market is segmented on the basis of type into NSAIDs, corticosteroids, hyaluronic acid injection, and others. The NSAIDs segment is expected to dominate the global market during the forecast period owing to their high usage rates for treating pain and inflammation associated with osteoarthritis. The corticosteroids segment is projected to grow at a higher CAGR than other segments during the forecast period due its ability to provide rapid relief from pain and inflammation associated with arthritis. On the basis of application, hospitals pharmacies accounted for majority share in 2017 owing high usage rates for prescription drugs used in treatment of various medical conditions including arthritis across all age groups.
Product Definition:
Osteoarthritis medications are drugs that are used to treat osteoarthritis. These drugs include both over-the-counter and prescription medications.
The primary purpose of these medications is to reduce pain and inflammation associated with the condition. They can also help improve joint function and mobility.
NSAIDs:
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) are used for the treatment of pain and inflammation associated with osteoarthritis. The global market is expected to grow at a lucrative rate during the forecast period owing to factors such as increasing geriatric population, rising prevalence of arthritis, and growing awareness about available treatments among patients.
Corticosteroids:
Corticosteroids are the group of drugs that act as anti-inflammatory agents. Corticosteroid medication is used to reduce inflammation in a variety of diseases such as asthma, rheumatoid arthritis, and Crohn's disease. The main function of corticosteroids is to suppress the immune response at the cellular level by inhibiting cytokines production.
Application Insights:
The joint pain application segment dominated the global osteoarthritis medications market in 2017, owing to the high prevalence of arthritis and other related conditions. According to a study published by the Centers for Disease Control and Prevention (CDC), around 54 million adults aged 18 years or older were affected with arthritis in 2016. The same study also stated that around 1 in 5 adults aged between 18-64 have suffered from some form of arthritis during their lifetime. As per another research paper published by National Center for Biotechnology Information (NCBI) in 2014, it was estimated that about 10% of total population of U.S., suffered from osteoarthritis during 2010-2014 period, which is expected to increase with aging process leading up to 2050 period when it will reach about 17%.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of key players, favorable reimbursement policies, and high healthcare expenditure are some factors driving the growth. In addition, growing prevalence of osteoarthritis is expected to fuel regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to increasing geriatric population and rising disposable income resulting in an increase in consumer health spending on medication for joint diseases such as osteoarthritis. Moreover, government initiatives for improving healthcare infrastructure are expected to drive demand over the next eight years. Increasing awareness regarding osteoarthritis treatment options will also contribute toward market growth during this period 8-year span). Furthermore, economic development coupled with improvements in living standards has led people from developing countries including India and China to migrate overseas which has resulted into increased medical tourism thus boosting product sales across these regions 8-year span).
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for osteoarthritis medications in the coming years.
- Rising awareness about osteoarthritis: There is a growing awareness about osteoarthritis among people and this is likely to boost the demand for these medications in the near future.
- Technological advancements: The development of new and innovative technologies has led to the introduction of novel drugs for treating osteoarthritis, which is likely to fuel market growth in the coming years.
- Growing prevalence of obesity: Obesity has been identified as one of the major risk factors for developing osteoarthritis and hence, there is a growing demand for effective treatments for this condition. This will spur market growth over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Osteoarthritis Medications Market Research Report
By Type
NSAIDs, Corticosteroids, Hyaluronic Acid Injection, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, Eli Lilly, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma, Flexion Therapeutics, Anika Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
177
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Osteoarthritis Medications Market Report Segments:
The global Osteoarthritis Medications market is segmented on the basis of:
Types
NSAIDs, Corticosteroids, Hyaluronic Acid Injection, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Johnson & Johnson
- GlaxoSmithKline
- Novartis
- Bayer
- Eli Lilly
- Sanofi
- Horizon Pharma
- Abbott
- Mylan
- Daiichi Sankyo
- TEVA
- Almatica Pharma
- Astellas Pharma
- Tide Pharmaceutical
- Iroko Pharmaceuticals
- Hengrui Pharmaceutical
- Abiogen Pharma
- Flexion Therapeutics
- Anika Therapeutics
Highlights of The Osteoarthritis Medications Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- NSAIDs
- Corticosteroids
- Hyaluronic Acid Injection
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Osteoarthritis Medications Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Osteoarthritis medications are drugs that help to relieve the symptoms of osteoarthritis. These medications can include painkillers, anti-inflammatory agents, and other treatments.
Some of the major companies in the osteoarthritis medications market are Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, Eli Lilly, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma, Flexion Therapeutics, Anika Therapeutics.
The osteoarthritis medications market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Osteoarthritis Medications Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Osteoarthritis Medications Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Osteoarthritis Medications Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Osteoarthritis Medications Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Osteoarthritis Medications Market Size & Forecast, 2018-2028
4.5.1 Osteoarthritis Medications Market Size and Y-o-Y Growth
4.5.2 Osteoarthritis Medications Market Absolute $ Opportunity
Chapter 5 Global Osteoarthritis Medications Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Osteoarthritis Medications Market Size Forecast by Type
5.2.1 NSAIDs
5.2.2 Corticosteroids
5.2.3 Hyaluronic Acid Injection
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Osteoarthritis Medications Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Osteoarthritis Medications Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Osteoarthritis Medications Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Osteoarthritis Medications Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Osteoarthritis Medications Analysis and Forecast
9.1 Introduction
9.2 North America Osteoarthritis Medications Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Osteoarthritis Medications Market Size Forecast by Type
9.6.1 NSAIDs
9.6.2 Corticosteroids
9.6.3 Hyaluronic Acid Injection
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Osteoarthritis Medications Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Osteoarthritis Medications Analysis and Forecast
10.1 Introduction
10.2 Europe Osteoarthritis Medications Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Osteoarthritis Medications Market Size Forecast by Type
10.6.1 NSAIDs
10.6.2 Corticosteroids
10.6.3 Hyaluronic Acid Injection
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Osteoarthritis Medications Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Osteoarthritis Medications Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Osteoarthritis Medications Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Osteoarthritis Medications Market Size Forecast by Type
11.6.1 NSAIDs
11.6.2 Corticosteroids
11.6.3 Hyaluronic Acid Injection
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Osteoarthritis Medications Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Osteoarthritis Medications Analysis and Forecast
12.1 Introduction
12.2 Latin America Osteoarthritis Medications Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Osteoarthritis Medications Market Size Forecast by Type
12.6.1 NSAIDs
12.6.2 Corticosteroids
12.6.3 Hyaluronic Acid Injection
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Osteoarthritis Medications Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Osteoarthritis Medications Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Osteoarthritis Medications Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Osteoarthritis Medications Market Size Forecast by Type
13.6.1 NSAIDs
13.6.2 Corticosteroids
13.6.3 Hyaluronic Acid Injection
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Osteoarthritis Medications Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Osteoarthritis Medications Market: Competitive Dashboard
14.2 Global Osteoarthritis Medications Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Johnson & Johnson
14.3.3 GlaxoSmithKline
14.3.4 Novartis
14.3.5 Bayer
14.3.6 Eli Lilly
14.3.7 Sanofi
14.3.8 Horizon Pharma
14.3.9 Abbott
14.3.10 Mylan
14.3.11 Daiichi Sankyo
14.3.12 TEVA
14.3.13 Almatica Pharma
14.3.14 Astellas Pharma
14.3.15 Tide Pharmaceutical
14.3.16 Iroko Pharmaceuticals
14.3.17 Hengrui Pharmaceutical
14.3.18 Abiogen Pharma
14.3.19 Flexion Therapeutics
14.3.20 Anika Therapeutics
